Weimin Mao Selected Research

Weimin Mao Research Topics

Disease

35	Neoplasms (Cancer) 04/2024 - 10/2008
24	Esophageal Squamous Cell Carcinoma 01/2024 - 11/2014
14	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2024 - 01/2013
12	Lung Neoplasms (Lung Cancer) 11/2018 - 10/2008
9	Esophageal Neoplasms (Esophageal Cancer) 01/2023 - 08/2012
8	Malignant Mesothelioma 01/2023 - 01/2017
8	Neoplasm Metastasis (Metastasis) 12/2021 - 10/2008
6	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2021 - 01/2015
5	Carcinoma (Carcinomatosis) 07/2021 - 01/2013
4	Adenocarcinoma 01/2021 - 01/2015
4	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 07/2017 - 09/2014
3	Carcinogenesis 01/2022 - 01/2012
3	Hemorrhage 02/2021 - 09/2017
3	Breast Neoplasms (Breast Cancer) 08/2017 - 01/2013
3	Brain Neoplasms (Brain Tumor) 07/2017 - 01/2013
2	Lymphatic Metastasis 12/2021 - 01/2018
2	Tuberculosis (Tuberculoses) 06/2018 - 10/2017
2	Infections 06/2018 - 03/2013
2	Neutropenia 01/2018 - 08/2016
2	Disease Progression 12/2013 - 12/2013
2	Onychomycosis (Tinea Unguium) 06/2007 - 07/2006
1	Central Nervous System Diseases (CNS Diseases) 04/2024
1	Colorectal Neoplasms (Colorectal Cancer) 11/2022
1	Pathologic Complete Response 12/2021
1	Pleural Effusion (Pleural Effusions) 08/2021
1	Adenocarcinoma of Lung 08/2021
1	Fistula 07/2020
1	Gastric Fistula 07/2020
1	Wounds and Injuries (Trauma) 12/2019
1	Lacerations 12/2019
1	Squamous Cell Carcinoma of Head and Neck 01/2019
1	Exanthema (Rash) 11/2018
1	Diabetes Mellitus 09/2018
1	Rare Diseases (Rare Disease) 01/2018

Drug/Important Bio-Agent (IBA)

9	Biomarkers (Surrogate Marker)IBA 01/2024 - 06/2017
9	Cisplatin (Platino)FDA LinkGeneric 12/2022 - 01/2013
7	AsbestosIBA 01/2023 - 01/2016
7	ErbB Receptors (EGF Receptor)IBA 12/2022 - 10/2009
7	Proteins (Proteins, Gene)FDA Link 01/2019 - 05/2015
4	Tyrosine Kinase InhibitorsIBA 08/2021 - 01/2013
4	MicroRNAs (MicroRNA)IBA 10/2020 - 10/2008
3	Vinorelbine (Navelbine)FDA LinkGeneric 12/2022 - 11/2018
3	Therapeutic UsesIBA 01/2019 - 01/2016
3	B7-H1 AntigenIBA 09/2017 - 05/2016
3	Long Noncoding RNAIBA 08/2017 - 01/2012
2	PlatinumIBA 04/2024 - 11/2015
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 12/2022 - 11/2018
2	LipidsIBA 11/2022 - 01/2022
2	ArsenicIBA 01/2021 - 12/2020
2	Pemetrexed (MTA)FDA Link 01/2021 - 01/2013
2	icotinibIBA 01/2021 - 09/2015
2	Transcription Factors (Transcription Factor)IBA 12/2020 - 08/2020
2	Indicators and Reagents (Reagents)IBA 12/2020 - 09/2017
2	130-nm albumin-bound paclitaxelIBA 01/2019 - 08/2016
2	ElementsIBA 01/2019 - 11/2018
2	RNA (Ribonucleic Acid)IBA 01/2019 - 01/2015
2	Immune Checkpoint InhibitorsIBA 11/2018 - 04/2017
2	Amino Acyl-tRNA Synthetases (Aminoacyl-tRNA Synthetase)IBA 10/2017 - 06/2007
2	Temozolomide (Temodar)FDA LinkGeneric 07/2017 - 01/2016
2	Messenger RNA (mRNA)IBA 01/2017 - 01/2012
2	EnzymesIBA 09/2015 - 06/2007
2	Paclitaxel (Taxol)FDA LinkGeneric 05/2015 - 12/2013
2	Carboplatin (JM8)FDA LinkGeneric 09/2014 - 12/2013
2	tavaboroleIBA 06/2007 - 07/2006
1	alectinibIBA 04/2024
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 11/2023
1	Epidermal Growth Factor (EGF)IBA 12/2022
1	sesaminIBA 01/2022
1	CarcinogensIBA 01/2022
1	Aurora Kinase AIBA 01/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2020
1	Ferrosoferric Oxide (Magnetite)FDA Link 12/2020
1	Cyclin D1IBA 01/2020
1	KynurenineIBA 01/2020
1	Arsenic Trioxide (Trisenox)FDA Link 01/2020
1	Hemostatics (Antihemorrhagics)IBA 12/2019
1	Cysteine (L-Cysteine)FDA Link 01/2019
1	TubulinIBA 01/2019
1	InterferonsIBA 11/2018
1	Metformin (Glucophage)FDA LinkGeneric 09/2018
1	AN12855IBA 06/2018
1	Polycomb Repressive Complex 2IBA 01/2018

Therapy/Procedure

17	Drug Therapy (Chemotherapy) 04/2024 - 01/2013
11	Neoadjuvant Therapy 01/2023 - 08/2012
10	Therapeutics 12/2022 - 07/2006
9	Radiotherapy 12/2020 - 09/2014
4	Esophagectomy 07/2020 - 05/2013
3	Chemoradiotherapy 01/2018 - 01/2015
2	Lymph Node Excision (Lymph Node Dissection) 01/2023 - 12/2019
2	Adjuvant Chemotherapy 12/2022 - 11/2018
2	Length of Stay 02/2021 - 09/2017
2	Thoracotomy 12/2019 - 09/2017
2	Aftercare (After-Treatment) 01/2019 - 01/2019
1	Oral Administration 01/2022
1	Segmental Mastectomy (Lumpectomy) 02/2021
1	Conservative Treatment 07/2020
1	Electrocoagulation (Electrocautery) 12/2019
1	Ligation 12/2019
1	Immunotherapy 11/2018
1	Minimally Invasive Surgical Procedures 10/2018